MA28698B1 - Dicetopiperazines substituees utilisees comme antagonistes des oxytocines - Google Patents

Dicetopiperazines substituees utilisees comme antagonistes des oxytocines

Info

Publication number
MA28698B1
MA28698B1 MA29584A MA29584A MA28698B1 MA 28698 B1 MA28698 B1 MA 28698B1 MA 29584 A MA29584 A MA 29584A MA 29584 A MA29584 A MA 29584A MA 28698 B1 MA28698 B1 MA 28698B1
Authority
MA
Morocco
Prior art keywords
oxytocines
dicetopiperazines
antagonists
substituted
substituted dicetopiperazines
Prior art date
Application number
MA29584A
Other languages
English (en)
Inventor
Alan David Borthwick
Steven Leslie Sollis
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MA28698B1 publication Critical patent/MA28698B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
MA29584A 2004-06-23 2006-12-29 Dicetopiperazines substituees utilisees comme antagonistes des oxytocines MA28698B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0414092.7A GB0414092D0 (en) 2004-06-23 2004-06-23 Novel compounds

Publications (1)

Publication Number Publication Date
MA28698B1 true MA28698B1 (fr) 2007-06-01

Family

ID=32800052

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29584A MA28698B1 (fr) 2004-06-23 2006-12-29 Dicetopiperazines substituees utilisees comme antagonistes des oxytocines

Country Status (18)

Country Link
US (1) US20070208031A1 (fr)
EP (1) EP1758893A1 (fr)
JP (1) JP2008503535A (fr)
CN (1) CN1989130A (fr)
AR (1) AR049651A1 (fr)
AU (1) AU2005256471A1 (fr)
BR (1) BRPI0512359A (fr)
CA (1) CA2571529A1 (fr)
GB (1) GB0414092D0 (fr)
IL (1) IL179912A0 (fr)
MA (1) MA28698B1 (fr)
MX (1) MXPA06014544A (fr)
NO (1) NO20070157L (fr)
PE (1) PE20060533A1 (fr)
RU (1) RU2007102272A (fr)
TW (1) TW200616635A (fr)
WO (1) WO2006000400A1 (fr)
ZA (1) ZA200610121B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2641806B1 (fr) * 1989-01-16 1992-05-07 Diffusion Rech Tech Financ Procede de stabilisation d'une aire de terrain meuble
GB0130677D0 (en) * 2001-12-21 2002-02-06 Glaxo Group Ltd Medicaments and novel compounds
GB0314738D0 (en) * 2003-06-24 2003-07-30 Glaxo Group Ltd Novel compounds
GB0414093D0 (en) 2004-06-23 2004-07-28 Glaxo Group Ltd Novel compounds
GB0414100D0 (en) * 2004-06-23 2004-07-28 Glaxo Group Ltd Novel compounds
CA2695384A1 (fr) 2007-07-31 2009-02-05 Burnham Institute For Medical Research Composes bidentate en tant qu'inhibiteurs de kinase
US20100038143A1 (en) * 2008-08-14 2010-02-18 George Alexander Burnett Drill cuttings treatment systems
US8716286B2 (en) 2009-10-30 2014-05-06 Glaxo Group Limited Crystalline forms of (3R, 6R)-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-2,5-piperazinedione
CN109305969B (zh) * 2017-07-27 2023-03-10 江苏恒瑞医药股份有限公司 哌嗪-2,5-二酮类衍生物、其制备方法及其在医药上的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130677D0 (en) * 2001-12-21 2002-02-06 Glaxo Group Ltd Medicaments and novel compounds
GB0414100D0 (en) * 2004-06-23 2004-07-28 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
AR049651A1 (es) 2006-08-23
JP2008503535A (ja) 2008-02-07
BRPI0512359A (pt) 2008-03-04
US20070208031A1 (en) 2007-09-06
GB0414092D0 (en) 2004-07-28
CN1989130A (zh) 2007-06-27
CA2571529A1 (fr) 2006-01-05
AU2005256471A1 (en) 2006-01-05
RU2007102272A (ru) 2008-07-27
WO2006000400A1 (fr) 2006-01-05
IL179912A0 (en) 2007-05-15
NO20070157L (no) 2007-01-23
ZA200610121B (en) 2008-08-27
EP1758893A1 (fr) 2007-03-07
PE20060533A1 (es) 2006-09-03
MXPA06014544A (es) 2007-03-12
TW200616635A (en) 2006-06-01

Similar Documents

Publication Publication Date Title
LTPA2017004I1 (lt) Chinazolinonai kaip žmogaus fosfatidilinozitol-3-kinazės-delta inhibitoriai
MA28822B1 (fr) Benzamides substitues trifluoromethyle comme inhibiteurs de kinase
DK1720866T3 (da) Fremgangsmåde
ITMI20041252A1 (it) Composizioni perfluoroelastomeriche
DK1940839T3 (da) Pyridopyrimidione Inhibitors of P13Ka
ATE414693T1 (de) Neuartige cis-imidazoline
ZA200801394B (en) Novel sulphonylpyrroles as inhibitors of HDAC S novel sulphonylpyrroles
IL184303A0 (en) Amino-pyridines as inhibitors of ??-secretase
DK2402005T3 (da) Formuleringer med langvarig frigivelse af nalbuphin
CY2013046I2 (el) Καινοτομος χρηση των αντισωματων αντι il-1bhta
MA28698B1 (fr) Dicetopiperazines substituees utilisees comme antagonistes des oxytocines
DE602005016978D1 (de) Quecksilberfreisetzende Zusammensetzungen
DK1776090T3 (da) Stabiliseret prostaglandinsammensætning
NO20055643D0 (no) Preparation of lodixanol
ATE404546T1 (de) Substituierte n-sulfonylaminobenzyl-2- phenoxyacetamidverbindungen
DE602005017191D1 (de) Geruchsreduzierte waschstück-zusammensetzung
FI20050969A (fi) Palamista ehkäisevät koostumukset
NO20043305D0 (no) Preparation of lodixanol
NO20070299L (no) Novel heterocyclic compounds
FR2877833B1 (fr) Correcteur de lordoses
FR2871686B1 (fr) Composition anti-decoloration
SE0402103D0 (sv) Novel compounds
NO20053517L (no) Anvendelse av lipidsenkende midler
DOP2004000824A (es) Nuevos derivados de 2-piridinacarboxamida
ITMO20040025A1 (it) Mezzi di collegamento